714
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The usefulness of mobile insulator sheets for the optimisation of deep heating area for regional hyperthermia using a capacitively coupled heating method: phantom, simulation and clinical prospective studies

, , , , , & show all
Pages 1092-1103 | Received 03 Sep 2016, Accepted 03 Nov 2017, Published online: 20 Nov 2017

References

  • Datta NR, Ordonez SG, Gaipl US, et al. (2015). Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 41:742–53.
  • van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–25.
  • Harima Y, Nagata K, Harima K, et al. (2001). A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97–105.
  • Overgaard J, Gonzalez DG, Hulshof MC, et al. (1996). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 12:3–20.
  • Jones EL, Samulski TV, Vujaskovic Z, et al. Hyperthermia, principles and practice of radiation oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
  • Harima Y, Ohguri T, Imada H, et al. (2016). A multicenter randomized clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia 32:801–8.
  • Ben-Hur E, Elkind MM. (1974). Thermally enhanced radioresponse of cultured Chinese hamster cells: damage and repair of single-stranded DNA and a DNA complex. Radiat Res 59:484–95.
  • Krawczyk PM, Eppink B, Essers J, et al. (2011). Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA 108:9851–6.
  • Issels R, Kampmann E, Kanaar R, Lindner LH. (2016). Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application. Int J Hyperthermia 32:89–95.
  • Oei AL, Vriend LE, Crezee J, et al. (2015). Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol 10:165.
  • Horsman MR, Overgaard J. (2007). Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 19:418–26.
  • Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. (1977). Cellular responses to combinations of hyperthermia and radiation. Radiology 123:463–74.
  • Sapareto SA, Hopwood LE, Dewey WC. (1978). Combined effects of X irradiation and hyperthermia on CHO cells for various temperatures and orders of application. Radiat Res 73:221–33.
  • van Rhoon GC. (2016). Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring?. Int J Hyperthermia 32:50–62.
  • Franckena M, Fatehi D, de Bruijne M, et al. (2009). Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 45:1969–78.
  • Ohguri T, Harima Y, Imada H, et al. (2017). Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial. Int J Hyperthermia [Epub ahead of print]. doi: 10.1080/02656736.2017.1352105
  • Sherar M, Liu FF, Pintilie M, et al. (1997). Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 39:371–80.
  • Bruggmoser G, Bauchowitz S, Canters R, et al. (2011). Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187:605–10.
  • Tanaka Y, Imada H, Hiraki Y, et al. (2007). The past and present status of clinical hyperthermia in Japan: a survey in 2004 using a questionnaire. Thermal Medicine 23:1–10.
  • van Rhoon GC, van der Zee J, Broekmeyer-Reurink MP, et al. (1992). Radiofrequency capacitive heating of deep-seated tumours using pre-cooling of the subcutaneous tissues: results on thermometry in Dutch patients. Int J Hyperthermia 8:843–54.
  • Song CW, Rhee JG, Lee CK, Levitt SH. (1986). Capacitive heating of phantom and human tumors with an 8 MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 12:365–72.
  • Takayama N, Okumura Y, Kimura T, et al. Applicator for hyperthermia. Kokai Jitsuyo Shinan Koho 1989; #20858.
  • Narabayashi I, Kawai T, Tatsumi T, Yachi K, Applicator for hyperthermia. Japan Patent Kokai 1993; #115561.
  • Abe M, Hiraoka M, Takahashi M, et al. (1986). Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 58:1589–95.
  • Hiraoka M, Jo S, Akuta K, et al. (1987). Radiofrequency capacitive hyperthermia for deep-seated tumors. II. Effects of thermoradiotherapy. Cancer 60:128–35.
  • Izukura R, Imada H, Hashiguchi N, et al. (2017). Cardiac and respiratory effects of deep regional hyperthermia using an 8-MHz radiofrequency-capacitive device on patients with cancer. Int J Hyperthermia 33:428–34.
  • Reddy NM, Balakrishnan IS, Bhaskar BK, et al. (1986). Optimization of power deposition and the rate of heating of tissue during RF capacitive hyperthermia. Int J Hyperthermia 2:321.
  • Brezovich IA, Lilly MB, Durant JR, Richards DB. (1981). A practical system for clinical radiofrequency hyperthermia. Int J Radiat Oncol Biol Phys 7:423–30.
  • Kato H, Hiraoka M, Ishida T. (1986). An agar phantom for hyperthermia. Med Phys 13:396–8.
  • Modeling for device design and personalized treatment planning. Sim4Life by ZMT. Available from: http://www.zurichmedtech.com/applications/thermal-therapies/ (2014). [last accessed 27 Jan 2017].
  • van der Zee J, Peer-Valstar JN, Rietveld PJ, et al. (1998). Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 40:1205–12.
  • Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. (2007). Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 183:479–86.
  • Oleson JR, Samulski TV, Leopold KA, et al. (1993). Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 25:289–97.
  • Jones EL, Oleson JR, Prosnitz LR, et al. (2005). Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–85.
  • Dewhirst MW, Viglianti BL, Lora-Michiels M, et al. (2003). Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 19:267–94.
  • Trefna HD, Crezee H, Schmidt M, et al. (2017). Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements. Int J Hyperthermia 33:471–82.
  • van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. (2008). The Kadota Fund International Forum 2004-clinical group consensus. Int J Hyperthermia 24:111–22.
  • Ohguri T, Imada H, Yahara K, et al. (2004). Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia 20:465–75.
  • Kroeze H, van de Kamer JB, de Leeuw AA, et al. (2003). Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia 19:58–73.
  • Tomimatsu A, Imada H, Kosaka K, et al. (1999). Advantage of an external cooling unit in deep hyperthermia using an 8 MHz RF capacitive heating device. Jpn J Hyperthermic Oncol 15:65–70.
  • Ohguri T, Yahara K, Moon SD, et al. (2011). Deep regional hyperthermia for the whole thoracic region using 8 MHz radiofrequency-capacitive heating device: relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int J Hyperthermia 27:20–6.
  • Yahara K, Ohguri T, Yamaguchi S, et al. (2015). Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: Thermal parameters correlated with biochemical relapse-free survival. Int J Hyperthermia 31:600–8.
  • Imada T, Nomoto S, Tomimatsu A, et al. (1999). Importance of patient positioning in hyperthermia for deep-seated intrathoracic tumors using an 8 MHz RF capacitive heating device. Jpn J Hyperthermic Oncol 15:15–9.
  • Tomimatsu A, Imada H, Kosaka K, et al. (1999). Refinement of circulating liquid of overlay bolus in hyperthermia using an 8 MHz RF capacitive heating device. Jpn J Hyperthermic Oncol 15:71–7.
  • Yanagawa S, Sone Y, Doi H, Yamamoto G. (1985). A new procedure for the prevention of surface overheating in deep hyperthermia using RF capacitive heating equipment. Jpn J Hyperthermic Oncol 1:187–91.
  • Karasawa K, Muta N, Nakagawa K, et al. (1994). Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 30:1171–7.
  • Rhee JG, Lee CK, Osborn J, et al. (1991). Precooling prevents overheating of subcutaneous fat in the use of RF capacitive heating. Int J Radiat Oncol Biol Phys 20:1009–15.
  • Kok HP, Wust P, Stauffer PR, et al. (2015). Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol 10:196.
  • Canters RA, Paulides MM, Franckena MF, et al. (2012). Implementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: an overview and the Rotterdam experience. Int J Hyperthermia 28:570–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.